top of page

Watch: Inside the KappaMab manufacturing process

Laptop On Tray_edited_edited_edited.jpg

14 June 2023

We’re pleased to announce that our third batch of our lead candidate, KappaMab, has arrived in Australia.

The drug is being stored at Cryosite and is ready to use in patients in the next planned clinical trial, which is a Phase II dose optimisation and combination study with Pomalidomide and dexamethasone.

This video takes you inside the state-of-the-art KappaMab manufacture process, which is subject to meticulous quality control that gives an incredibly low rejection rate of less than 1%.

Video: Inside the KappaMab manufacturing process 

bottom of page